Wespac Advisors, LLC Edwards Lifesciences Corp Transaction History

Wespac Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$86.5 - $128.27 $39,098 - $57,978	452 Added 9.37%	5,277 $502,000
Q1 2022 Apr 27, 2022	BUY	$101.96 - $128.34 $89,113 - $112,169	874 Added 22.12%	4,825 $568,000
Q4 2021 Jan 28, 2022	SELL	$106.37 - $130.68 $289,751 - $355,972	-2,724 Reduced 40.81%	3,951 $512,000
Q3 2021 Oct 14, 2021	BUY	$102.91 - $122.75 $686,924 - $819,356	6,675 New	6,675 $756,000
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $205,743 - $257,081	-2,454 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$71.69 - $91.23 $175,927 - $223,878	2,454 New	2,454 $224,000
Q1 2020 Apr 22, 2020	SELL	$52.41 - $81.0 $165,720 - $256,122	-3,162 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $3,585 - $4,104	-50 Reduced 1.56%	3,162 $738,000
Q3 2019 Oct 29, 2019	BUY	$61.55 - $75.43 $197,698 - $242,281	3,212 New	3,212 $706,000
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $75,926 - $93,153	-1,636 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$45.7 - $58.03 $74,765 - $94,937	1,636 New	1,636 $285,000
Q2 2018 Aug 08, 2018	SELL	$42.45 - $51.3 $69,745 - $84,285	-1,643 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$37.19 - $47.45 $61,103 - $77,960	1,643 New	1,643 $229,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.